Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
Endocrinology and Metabolism
;
: 717-724, 2021.
Article
in English
| WPRIM
| ID: wpr-890497
ABSTRACT
Active surveillance (AS) for low-risk papillary thyroid microcarcinoma (PTMC) has been accepted worldwide as safe and effective. Despite the growing acceptance of AS in the management of low-risk PTMCs, there are barriers to AS in real clinical settings, and it is important to understand and establish appropriate AS protocol from initial evaluation to follow-up. PTMC management strategies should be decided upon after careful consideration of patient and tumor characteristics by a multidisciplinary team of thyroid cancer specialists. Patients should understand the risks and benefits of AS, participate in decision-making and follow structured monitoring strategies. In this review, we discuss clinical outcomes of AS from previous studies, optimal indications and follow-up strategies for AS, and unresolved questions about AS.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Etiology study
/
Practice guideline
/
Prognostic study
/
Screening study
Language:
English
Journal:
Endocrinology and Metabolism
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS